A population of adults (≥18 years) with T2DM and studies focusing primarily on intervention as any GLP-1 RA (e.g., liraglutide, semaglutide, dulaglutide, and exenatide) were included. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.